Envoy Medical Extends Shortfall Warrants, Enhancing Capital Flexibility
TipRanks (Mon, 29-Dec 4:37 PM ET)
Newsfile (Thu, 18-Dec 8:01 AM ET)
Newsfile (Tue, 16-Dec 8:01 AM ET)
Newsfile (Wed, 10-Dec 8:00 AM ET)
Newsfile (Thu, 4-Dec 8:00 AM ET)
Envoy Medical Announces the Grant of Its 40th U.S. Patent
Newsfile (Tue, 2-Dec 8:01 AM ET)
Newsfile (Thu, 20-Nov 8:00 AM ET)
Newsfile (Tue, 18-Nov 8:01 AM ET)
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
Newsfile (Mon, 10-Nov 8:01 AM ET)
Newsfile (Tue, 4-Nov 8:01 AM ET)
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.
As of December 29, 2025, COCH stock price declined to $0.70 with 125,409 million shares trading.
COCH has a beta of 0.15, meaning it tends to be less sensitive to market movements. COCH has a correlation of 0.00 to the broad based SPY ETF.
COCH has a market cap of $20.25 million. This is considered a Sub-Micro Cap stock.
Last quarter Envoy Medical - Class A reported $42,000 in Revenue and -$.35 earnings per share. This fell short of revenue expectation by $-30,000 and missed earnings estimates by -$.07.
The top ETF exchange traded funds that COCH belongs to (by Net Assets): VTI, IWC, VXF.
COCH has underperformed the market in the last year with a price return of -56.3% while the SPY ETF gained +16.8%. COCH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.5% and -6.9%, respectively, while the SPY returned +3.9% and +1.3%, respectively.
COCH support price is $.69 and resistance is $.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.
